此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

追踪泌尿外科门诊患者的人工智能/大型语言模型素养与知识 (TALK-U) (TALK-U)

TALK-U研究:追踪泌尿外科门诊患者中人工智能/大语言模型的知识与应用及其与焦虑、满意度和健康意识的关联——一项横断面研究

This study is a one-time, questionnaire-based survey of adults attending a urology outpatient clinic. The investigators will examine whether patients who use AI chat tools based on large language models (LLMs), such as ChatGPT, before seeking care differ from non-users in (1) anxiety, (2) satisfaction with the clinic visit, and (3) awareness/understanding of their health condition.

Participants who provide written informed consent will complete a brief survey during their clinic visit (about 5-7 minutes). The survey includes a standardized anxiety scale (GAD-7), visual analog scales (0-10) for anxiety before and after the visit, satisfaction, and disease awareness, as well as questions about AI/LLM knowledge and use. Treating clinicians will not have access to participants' survey responses, and participation will not affect clinical care.

研究概览

地位

完全的

详细说明

The TALK-U study is a cross-sectional, observational survey conducted in the urology outpatient clinic of Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. The primary exposure is self-reported AI/LLM knowledge and use for health information (e.g., whether participants have used ChatGPT or similar tools, frequency, awareness of AI, and purpose of use). The primary outcome is anxiety measured by GAD-7 at the time of the clinic encounter. Secondary outcomes include (i) anxiety assessed on a 0-10 visual analog scale before and after the visit, (ii) outpatient visit satisfaction (0-10 VAS), and (iii) perceived disease awareness/understanding (0-10 VAS).

Eligible adult first-time urology outpatients who can complete the survey independently and provide informed consent will be invited during a 2-month recruitment period. Analyses will compare outcomes between AI/LLM users and non-users and explore associations with age group (<40, 40-60, >60), education level, and urology subspecialty category. Data will be analyzed using appropriate parametric/nonparametric tests depending on distribution, with p < 0.05 considered statistically significant.

研究类型

观察性的

注册 (实际的)

1005

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Yenimahalle/Ankara
      • Ankara、Yenimahalle/Ankara、土耳其(türkiye)、06200
        • Dr.Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Adult patients (≥18 years) presenting for a first-time visit to the Urology Outpatient Clinic at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital will be invited to participate during a 2-month recruitment period. Participants who provide written informed consent and can complete a brief questionnaire independently will be enrolled. The study will include both sexes and a broad range of urologic presenting complaints.

描述

Inclusion Criteria:

  • Age 18 years or older
  • First-time visit to the Urology Outpatient Clinic
  • Able to read and write and complete the questionnaire independently
  • Able to provide written informed consent

Exclusion Criteria:

  • Age under 18 years
  • Insufficient literacy to understand and complete the questionnaire
  • Severe hearing or visual impairment, or a neurological/psychiatric condition that prevents understanding and completing the survey
  • Refusal or inability to provide informed consent
  • Currently under follow-up for a known urologic condition (i.e., not a first-time urology outpatient visit)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:CASE_CONTROL
  • 时间观点:CROSS_SECTIONAL

队列和干预

团体/队列
AI/LLM users

Participants who report prior use of AI chat tools based on large language models (e.g., ChatGPT or similar) for health information before the outpatient urology visit, as assessed by the study questionnaire.

non AI/LLM users

Participants who report no prior use of AI/LLM chat tools (e.g., ChatGPT or similar) for health information before the outpatient urology visit, as assessed by the study questionnaire.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Pre-visit Anxiety (VAS 0-10)
大体时间:Day 0 (immediately before the outpatient visit)

Self-rated anxiety on a 0-10 visual analog scale (VAS), where 0 indicates no anxiety and 10 indicates the highest possible anxiety. This measure reflects visit-related state anxiety prior to clinician encounter.

Day 0 (immediately before the outpatient visit)

次要结果测量

结果测量
措施说明
大体时间
Post-visit Anxiety (VAS 0-10)
大体时间:Day 0 (immediately after the outpatient visit)

Self-rated anxiety on a 0-10 VAS (0 = none, 10 = highest).

Day 0 (immediately after the outpatient visit)
Visit Satisfaction (VAS 0-10)
大体时间:Day 0 (immediately after the outpatient visit)

Self-rated satisfaction with the outpatient visit on a 0-10 VAS (0 = not satisfied at all, 10 = maximum satisfaction).

Day 0 (immediately after the outpatient visit)
Disease Awareness/Understanding (VAS 0-10)
大体时间:Day 0 (during the outpatient clinic visit)

Self-rated awareness/understanding of one's condition on a 0-10 VAS (0 = none, 10 = complete).

Day 0 (during the outpatient clinic visit)

其他结果措施

结果测量
措施说明
大体时间
Baseline General Anxiety Symptoms (GAD-7 Total Score)
大体时间:Day 0 (at enrollment; prior to or during the clinic visit)

Total score on the 7-item GAD-7 questionnaire (range 0-21; higher scores indicate greater generalized anxiety symptoms). This measure will be used to account for baseline anxiety (trait-like symptoms) and to adjust analyses of VAS-based state anxiety out

Day 0 (at enrollment; prior to or during the clinic visit)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年1月1日

初级完成 (实际的)

2026年3月1日

研究完成 (实际的)

2026年3月1日

研究注册日期

首次提交

2025年12月24日

首先提交符合 QC 标准的

2025年12月24日

首次发布 (实际的)

2026年1月8日

研究记录更新

最后更新发布 (实际的)

2026年11月17日

上次提交的符合 QC 标准的更新

2026年11月15日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅